RBC Capital analyst Benjamin Toms maintained a Hold rating on Banco Santander (BNC – Research Report) today and set a price target of €5.90. The company’s shares closed today at p454.50.
Goldman Sachs upgraded Santander Brasil (BSBR) to Neutral from Sell with a price target of $4.70, up from $4.20. The firm sees the bank’s return on equity remaining stable at 17% in 2025 and 2026.
Banco Santander SA Chairman Ana Botin said the lender can shift resources away from lower-perfoming units and doesn’t need to sell them when asked about the future of the lender’s UK operations.
The total is set to grow as firms from Banco Santander SA to Deutsche Bank AG commit to distributing billions more.
Santander had lagged rivals such as BBVA (BBVA.MC), opens new tab in prioritising shareholder payouts, and its shares had underperformed its Spanish rival until recently. On Wednesday the bank ...
But Santander’s boss Ana Botin has insisted the bank will remain operating in the UK. “The UK is not for sale,” Ms Botin told The Sunday Times. “We love the UK and the UK will remain a ...
After missing out on many of their top free-agent targets in recent weeks, the Toronto Blue Jays have finally made a splash by landing slugger Anthony Santander. The two sides have agreed to a ...
Globant (NYSE: GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, today announced it will release results for the fourth quarter and full year ...
Removes regional Europe, North America, South America units Changes part of simpler structure around five global units Andres ...
Outfielder Anthony Santander has signed with the Toronto Blue Jays, reports MLB Network's Jon Paul Morosi. The switch-hitting slugger agreed to a five-year deal with Toronto worth $92.5 million ...
The Toronto Blue Jays finally landed a high-profile free agent, adding Anthony Santander to their powerful lineup, according to a person with direct knowledge of the agreement. The person spoke on ...
MidEuropa, a leading private equity investor with deep roots in Central Europe, announces that its portfolio company, Diagnostyka, a leading provider of medical diagnostic services in Poland, has ...